Page 12 - Pharmaceutical Firms

Coronavirus a game-changer, can't rely on China for drug supply: French FM

And the resulting industrial slowdown in China would have a "direct impact" on industrial resupply, he said

Firms in pharma supply chain develop system to track counterfeit drugs

Medicines identified as counterfeit may be contaminated, contain the wrong ingredient, or have no active ingredient at all

Budget 2020: Jan Aushadhi growth could hurt branded pharma market

In the 2020-21 Union Budget, finance minister Nirmala Sitharaman proposed to expand the scheme to all districts, and offer 2,000 medicines and 300 surgicals by 2024

Govt plans single-window assistance mechanism for pharma investors by March

On the sidelines of an annual event of the Indian Drug Manufacturers' Association, a senior government official said plans had been readied in this regard

Online pharmacies see record funding in 2019, investments double to $321 mn

The industry experts are expecting more activity in the segment, especially if a delayed regulatory framework takes place during the current year.

Uptick in domestic segment, biz growth continue to drive Ipca Laboratories

Further rerating of stock will hinge on USFDA resolution

Legacy pharma brands spin gold for GSK, Pfizer; keep newcomers off the turf

Repositioning an old brand helps expand the footprint, say analysts

Novartis, Merck, Allergan raise US prices, 445 drugs to cost more in 2020

That is above the average of 404 drug price increases in the first three days of January over the past five years

Biocon and Equillium Inc. expand license agreement for itolizumab

The companies have expanded their collaboration and license agreement

SME Tracker: Bulk-drug firms' prospects boosted by focus on niche molecules

Strong demand for formulations and increasing health insurance penetration would also support growth

India may overhaul clinical trial ecosystem for faster drug availability

At a meeting last month, government officials discussed the proposal to set up clinical trial centres at institutions affiliated with the ICMR, replacing the current system

Eris Lifesciences soars 7%, hits five-month high in a weak market

In October, some large domestic mutual funds took an aggressive position in the stock, monthly disclosures show

Piramal Pharma partners with Norway firm to develop leukemia treatment drug

Piramal Pharma Solutions will partner, Bemcentinib, an AXL protein inhibitor for oncology which was recently designated as a Fast Track drug by the US Food and Drug Administration

Strong domestic and export growth to drive Ipca Laboratories' earnings

Ipca's first half performance holds testimony to its robust growth with India business growing in mid-teens

Textiles to pharma: India's deepening slowdown explained in six charts

What could be the reason for these successive downward revisions across the board? Some key indicators make it evident.

Aurobindo Pharma receives 8 US FDA observations for two of its facilities

Observations are related to procedural improvements, not data integrity, says the company

Medicines costing less than Rs 5 per dose may be taken out of price control

If this goes through, drugmakers will have the liberty to raise the prices of these drugs by up to 10 per cent every year

GSK gains 38% over 3 months, gets boost from tighter low-end portfolio

Revenue growth, margins have been trending up over the past couple of quarters

Glenmark Pharmaceuticals shareholders may get higher dividend in FY21

Monetisation of API, innovative business units planned this year

Drug regulator making list of dual-use APIs imported from unregistered cos

The CDSCO is strictly monitoring the import of such dual-use APIs for the last few months so as to get an idea on what kind of action should be taken